topiramate and Behcet-Syndrome

topiramate has been researched along with Behcet-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for topiramate and Behcet-Syndrome

Article	Year
Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome. Headache, 2004, Volume: 44, Issue:5 A 14-year-old adolescent was seen with an 8-month history of almost daily incapacitating headaches due to idiopathic intracranial hypertension in Behçet syndrome. All his clinical signs and symptoms, including headache, resolved 2 to 4 weeks after topiramate was initiated. An effect on carbonic anhydrase isoenzymes II and IV, reducing cerebrospinal fluid production, could potentially explain the beneficial effect of topiramate in intracranial hypertension. Further studies are necessary, however, to confirm the significance of topiramate in this indication. Topics: Adolescent; Anticonvulsants; Behcet Syndrome; Fructose; Headache; Humans; Male; Pseudotumor Cerebri; Topiramate	2004

Article

Year

Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome.

Headache, 2004, Volume: 44, Issue:5

A 14-year-old adolescent was seen with an 8-month history of almost daily incapacitating headaches due to idiopathic intracranial hypertension in Behçet syndrome. All his clinical signs and symptoms, including headache, resolved 2 to 4 weeks after topiramate was initiated. An effect on carbonic anhydrase isoenzymes II and IV, reducing cerebrospinal fluid production, could potentially explain the beneficial effect of topiramate in intracranial hypertension. Further studies are necessary, however, to confirm the significance of topiramate in this indication.

Topics: Adolescent; Anticonvulsants; Behcet Syndrome; Fructose; Headache; Humans; Male; Pseudotumor Cerebri; Topiramate

2004